Atossa Therapeutics Inc (ATOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,080 | -9,589 | -34,770 | -23,833 | -15,141 |
| Depreciation Amortization | 8 | 4 | 16 | 12 | 8 |
| Accounts payable and accrued liabilities | -2,317 | -1,724 | 3,614 | 2,853 | 1,331 |
| Other Working Capital | -2,690 | -718 | 2,346 | 2,455 | 556 |
| Other Operating Activity | 3,854 | 2,446 | -968 | -710 | 28 |
| Operating Cash Flow | $-19,225 | $-9,581 | $-29,762 | $-19,223 | $-13,218 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -23 | -16 | -9 |
| Investing Cash Flow | $N/A | $N/A | $-23 | $-16 | $-9 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,521 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -501 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $4,020 | $N/A | $N/A | $N/A | $N/A |
| Beginning Cash Position | 41,409 | 41,409 | 71,194 | 71,194 | 71,194 |
| End Cash Position | 26,204 | 31,828 | 41,409 | 51,955 | 57,967 |
| Net Cash Flow | $-15,205 | $-9,581 | $-29,785 | $-19,239 | $-13,227 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,225 | -9,581 | -29,762 | -19,223 | -13,218 |
| Capital Expenditure | N/A | N/A | -23 | -16 | -9 |
| Free Cash Flow | -19,225 | -9,581 | -29,785 | -19,239 | -13,227 |